PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 163 filers reported holding PDL BIOPHARMA INC in Q2 2018. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,555,000 | -21.4% | 493,774 | -27.4% | 0.00% | -25.0% |
| Q2 2020 | $1,979,000 | +4022.9% | 680,071 | +4346.7% | 0.00% | – |
| Q2 2019 | $48,000 | -98.5% | 15,294 | -98.2% | 0.00% | -100.0% |
| Q1 2019 | $3,136,000 | +124.3% | 842,869 | +74.8% | 0.01% | +150.0% |
| Q4 2018 | $1,398,000 | +3395.0% | 482,130 | +3050.4% | 0.00% | – |
| Q3 2018 | $40,000 | -96.6% | 15,304 | -96.9% | 0.00% | -100.0% |
| Q2 2018 | $1,161,000 | -48.1% | 496,161 | -34.8% | 0.00% | -33.3% |
| Q1 2018 | $2,236,000 | -21.1% | 760,461 | -26.5% | 0.00% | -25.0% |
| Q4 2017 | $2,835,000 | -33.2% | 1,034,361 | -17.4% | 0.00% | -33.3% |
| Q3 2017 | $4,243,000 | +98.6% | 1,251,794 | +44.8% | 0.01% | +100.0% |
| Q2 2017 | $2,136,000 | +7.0% | 864,634 | -1.7% | 0.00% | 0.0% |
| Q1 2017 | $1,996,000 | -1.4% | 879,254 | -7.9% | 0.00% | 0.0% |
| Q4 2016 | $2,024,000 | -39.2% | 954,854 | -3.9% | 0.00% | -40.0% |
| Q3 2016 | $3,328,000 | +14.0% | 993,454 | +6.8% | 0.01% | 0.0% |
| Q2 2016 | $2,920,000 | +20.4% | 929,864 | +27.6% | 0.01% | +25.0% |
| Q1 2016 | $2,426,000 | +1302.3% | 728,564 | +1394.1% | 0.00% | – |
| Q4 2015 | $173,000 | +111.0% | 48,764 | +199.8% | 0.00% | – |
| Q3 2015 | $82,000 | -20.4% | 16,264 | +1.2% | 0.00% | – |
| Q2 2015 | $103,000 | -9.6% | 16,064 | -1.2% | 0.00% | – |
| Q1 2015 | $114,000 | -8.1% | 16,264 | +1.2% | 0.00% | – |
| Q4 2014 | $124,000 | -25.7% | 16,064 | -28.2% | 0.00% | – |
| Q3 2014 | $167,000 | -86.6% | 22,364 | -82.7% | 0.00% | -100.0% |
| Q2 2014 | $1,248,000 | +78.0% | 128,919 | +52.8% | 0.00% | +100.0% |
| Q1 2014 | $701,000 | -0.4% | 84,364 | +1.2% | 0.00% | 0.0% |
| Q4 2013 | $704,000 | +7.5% | 83,364 | +1.5% | 0.00% | 0.0% |
| Q3 2013 | $655,000 | -7.5% | 82,164 | -10.4% | 0.00% | -50.0% |
| Q2 2013 | $708,000 | – | 91,735 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 158,634 | $528,000 | 0.73% |
| TFS CAPITAL LLC | 795,409 | $2,649,000 | 0.38% |
| Dynamic Capital Management Ltd | 173,813 | $579,000 | 0.22% |
| Acrospire Investment Management LLC | 91,141 | $303,000 | 0.21% |
| GSA CAPITAL PARTNERS LLP | 905,024 | $3,014,000 | 0.19% |
| RBF Capital, LLC | 273,976 | $912,000 | 0.18% |
| Gotham Asset Management, LLC | 3,732,679 | $12,430,000 | 0.14% |
| Advisors Asset Management, Inc. | 2,362,054 | $7,866,000 | 0.13% |
| A.R.T. Advisors, LLC | 812,008 | $2,703,000 | 0.12% |
| Bayesian Capital Management, LP | 37,200 | $124,000 | 0.12% |